Clinical trial

Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute…

NCT00003728 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Unknown status

Key facts

NCT number NCT00003728
Title Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma
Official title The Value of Dexamethasone Versus Prednisolone During Induction and Maintenance Therapy of Prolonged Versus Conventional Duration of L-Asparaginase Therapy During Consolidation and Late Intensification, and of Corticosteroid + VCR Pulses During Maintenance in Acute Lymphoblastic Leukemia and…
Lead sponsor European Organisation for Research and Treatment of Cancer - EORTC, Other
Status Unknown status
Phase Phase 3
Study type Interventional
Conditions Leukemia, Lymphoma
Intervention type Drug, Procedure
Interventions asparaginase, cyclophosphamide, cytarabine, daunorubicin hydrochloride, dexamethasone, doxorubicin hydrochloride, etoposide, leucovorin calcium, mercaptopurine, methotrexate and 9 more
Enrollment 1,500
Start date Dec 1, 1998
Primary completion May 1, 2008
First posted Jan 27, 2003
Last update posted Jan 21, 2011
Countries Belgium, France, Portugal

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies